Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Gradual increases give you a buffer against these small variations
It is often sold alongside research peptides because it fits the same metabolic research space, but chemically it is closer to a small-molecule drug than to peptides like BPC-157 or semaglutide
AOD-9604 and Tesamorelin in Combination Research The theoretical basis for discussing AOD-9604 alongside Tesamorelin comes from their non-overlapping mechanisms: AOD-9604 acts locally on fat tissue without engaging the GH/IGF-1 axis, while Tesamorelin works upstream by stimulating pituitary GH release
Lancet 390 (10113), 26272642
The injection technique guide covers site selection in detail
